BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Up 373.4% in June

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 349,174 shares, an increase of 373.4% from the June 15th total of 73,761 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average daily volume of 570,441 shares, the days-to-cover ratio is presently 0.6 days.

BetterLife Pharma Stock Performance

OTCMKTS BETRF opened at $0.13 on Monday. The company’s fifty day moving average is $0.07 and its two-hundred day moving average is $0.05. BetterLife Pharma has a 52-week low of $0.03 and a 52-week high of $0.15.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders.